Eric Green, M.D., Ph.D., Promoted to Chief Scientific Officer
SOUTH SAN FRANCISCO, Calif., October 13, 2022--(BUSINESS WIRE)--Maze Therapeutics, a institution translating familial insights into caller precision medicines, contiguous announced that Harold Bernstein, M.D., Ph.D., a 30-year manufacture veteran, has been appointed arsenic president, caput of probe and improvement (R&D) and main aesculapian officer. In addition, Eric Green, M.D., Ph.D., who has served arsenic Maze’s elder vice president, probe and translational sciences, has been promoted to main technological officer.
"Harold brings an awesome operation of manufacture and world experience, arsenic good arsenic the unsocial position of a practicing physician, to the Maze squad astatine an important signifier of our development. Further, with overmuch of Harold’s acquisition having focused connected quality genetics, helium is simply a earthy campaigner for this position, and I’m thrilled to invited him to our squad and mission," said Jason Coloma, Ph.D., main enforcement serviceman of Maze. "I americium besides pleased to denote the promotion of Eric to CSO, who has been a existent person and driving unit down overmuch of Maze’s level and pipeline advancement since our founding. Eric and Harold volition beryllium instrumental successful executing the advancement of our divers pipeline, which spans monogenic diseases similar Pompe disease, and much analyzable diseases, similar chronic kidney disease. I look guardant to partnering with these 2 experts arsenic we present connected our imaginativeness of harnessing the powerfulness of quality genetics to alteration the lives of patients."
"Maze has attracted immoderate of the champion minds successful biotech and has proven itself done awesome advancement since its founding, including the build-out of its Compass level and accelerated advancement into the clinic," said Dr. Bernstein. "I was drawn to the Maze team’s lofty extremity of shifting the paradigm successful medicine, successful peculiar for much analyzable diseases specified arsenic chronic kidney disease, during an unprecedented clip for the tract of genetics and precision medicine. As caput of R&D, I look guardant to shaping and contributing to a originative strategy and thorough technological process aimed astatine delivering new, genetic-based medicines. I americium thrilled to articulation the Maze squad arsenic we urgently enactment to make and beforehand therapeutically meaningful treatments to assistance patients successful need."
Dr. Bernstein brings much than 3 decades of acquisition successful basal technological research, translational medicine and objective improvement some successful manufacture and academia. He joins Maze from BioMarin, wherever helium served arsenic elder vice president, main aesculapian serviceman and caput of planetary objective development. In this role, helium was liable for fortifying objective improvement from aboriginal to precocious stages, moving seamlessly with probe find and overseeing the late-stage and lifecycle products. Prior to BioMarin, helium was caput of translational medicine and vice president of planetary medicines improvement and aesculapian affairs astatine Vertex, and earlier held roles astatine Merck, including caput of aboriginal improvement for cardiometabolic diseases. Dr. Bernstein was prof of pediatrics and a elder researcher astatine the Cardiovascular Research Institute and the Broad Center of Regeneration Medicine and Stem Cell Research astatine the University of California, San Francisco (UCSF). He besides served arsenic attending doc astatine UCSF Benioff Children’s Hospital successful pediatric cardiology, and astatine the Mount Sinai Kravis Children’s Hospital successful cardiovascular genetics. Dr. Bernstein presently holds an assignment arsenic adjunct prof of pediatrics and the Mindich Child Health and Development Institute astatine the Icahn School of Medicine astatine Mount Sinai. He studied biomedical science, quality genetics and medicine astatine the Mount Sinai School of Medicine, earning an M.Phil., Ph.D. and M.D. He completed a pediatric residency, cardiology fellowship and postdoctoral fellowship astatine UCSF and earned an A.B. successful biologic sciences from Harvard College.
Dr. Green is simply a physician-scientist and entrepreneur with much than 15 years of acquisition gathering and operating innovative technological organizations. Prior to Maze, Dr. Green was an entrepreneur-in-residence astatine Third Rock Ventures, wherever helium was progressive successful launching and gathering aggregate Third Rock portfolio companies, including MyoKardia wherever helium led the translational probe radical moving connected mavacamten, which was yet acquired by Bristol Myers Squibb. Dr. Green is simply a board-certified doc with grooming successful interior medicine and cardiovascular medicine from Brigham and Women’s Hospital. He holds an M.D. and Ph.D. successful chemic and systems biology from Stanford University and an A.B. successful past and subject from Harvard College.
About Maze Therapeutics
Maze Therapeutics is simply a biopharmaceutical institution applying precocious information subject methods successful tandem with a robust suite of probe and improvement capabilities to beforehand a pipeline of caller precision medicines for patients with genetically defined diseases. Maze has developed the Maze CompassTM platform, a proprietary, purpose-built level that combines quality familial data, functional genomic tools and information subject exertion to representation caller connections betwixt known genes and their power connected susceptibility, timing of onset and complaint of illness progression. Using Compass, Maze is gathering a wide portfolio of wholly owned and partnered programs. Maze is based successful South San Francisco. For much information, delight sojourn mazetx.com, oregon travel america connected LinkedIn and Twitter.
View root mentation connected businesswire.com: https://www.businesswire.com/news/home/20221013005211/en/
Contacts
Jillian Connell, Maze Therapeutics
jconnell@mazetx.com
650.850.5080
Media:
Katie Engleman, 1AB
katie@1abmedia.com
English (US)